# Cencora

> Cencora is a global pharmaceutical distribution and services company connecting drug manufacturers with pharmacies, hospitals, physician practices and patients. Formerly AmerisourceBergen, it combines wholesale distribution with specialty logistics, commercialization consulting, patient support and practice management services.

- **Founded:** 2001
- **Headquarters:** Conshohocken, United States
- **Products:** Wholesale and specialty distribution, World Courier, Cocoon, Good Neighbor Pharmacy, Biopharma services / PharmaLex
- **Notable:** Formed through the 2001 AmeriSource and Bergen Brunswig merger., Completed the majority Alliance Healthcare acquisition in June 2021., Changed its name and NYSE ticker to Cencora and COR on August 30, 2023.

## Products & services

- **Wholesale and specialty distribution** — Pharmaceutical sourcing, distribution, inventory and supply chain services for pharmacies, health systems and specialty practices.
- **World Courier** — Specialty pharmaceutical transportation, clinical trial logistics, storage and temperature-controlled shipping.
- **Cocoon** — Reusable passive temperature-controlled pallet shipping containers from World Courier.
- **Good Neighbor Pharmacy** — Business, branding and operational support for independent community pharmacies.
- **Biopharma services / PharmaLex** — Regulatory affairs, development consulting, pharmacovigilance, quality and commercialization support.
- **Patient access and adherence support** — Services that help manufacturers and providers address barriers to starting and continuing treatment.
- **OneOncology** — Physician-led platform supporting independent specialty practices rooted in oncology; majority acquisition completed February 2026.
- **Retina Consultants of America** — Management services organization supporting retina specialist practices; majority acquired January 2025.
- **MWI Animal Health** — Distribution and business services for animal health providers.

## Achievements

- Formed through the 2001 AmeriSource and Bergen Brunswig merger.
- Completed the majority Alliance Healthcare acquisition in June 2021.
- Changed its name and NYSE ticker to Cencora and COR on August 30, 2023.
- Reported $321.3 billion in fiscal 2025 revenue.
- Completed majority acquisitions of RCA in January 2025 and OneOncology in February 2026.

## Latest updates

- **2026-10** — On October 21, signed an agreement to acquire American Oncology Network at an enterprise value of $2.4 billion, including up to $100 million in contingent value rights; closing remains subject to approvals and conditions.
- **2026-02** — Completed the majority OneOncology acquisition on February 2 for approximately $4.6 billion cash consideration, funded with new debt.
- **2025-11** — Announced $1 billion of planned U.S. distribution investment through 2030.

## Links

- Website: https://www.cencora.com/
- LinkedIn: https://www.linkedin.com/company/cencoraglobal/
- Twitter/X: https://www.twitter.com/CencoraGlobal
- Instagram: https://www.instagram.com/cencoraglobal/
- Facebook: https://www.facebook.com/Cencora

---

Profile page: https://yespress.io/cencora
Published by YesPress — https://yespress.io
Last updated: 2026-10-22